Nolte, Kathleen

[["dc.bibliographiccitation.journal","European Journal of Heart Failure"],["dc.bibliographiccitation.volume","17"],["dc.contributor.author","Duvinage, Andre"],["dc.contributor.author","Stahrenberg, Raoul"],["dc.contributor.author","Bueren, F. To"],["dc.contributor.author","Nolte, K."],["dc.contributor.author","Mende, Meinhard"],["dc.contributor.author","Pieske, Burkert M."],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Wachter, R. Rolf"],["dc.contributor.author","Edelmann, F."],["dc.date.accessioned","2018-11-07T09:57:28Z"],["dc.date.available","2018-11-07T09:57:28Z"],["dc.date.issued","2015"],["dc.format.extent","420"],["dc.identifier.isi","000366200403599"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37164"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Hoboken"],["dc.relation.issn","1879-0844"],["dc.relation.issn","1388-9842"],["dc.title","Combination of neurohormones and clinical signs and symptoms to detect a left ventricular dysfunction"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","European Journal of Heart Failure"],["dc.bibliographiccitation.volume","17"],["dc.contributor.author","Nolte, K. Kathleen"],["dc.contributor.author","Wachter, R. Rolf"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Platschek, L."],["dc.contributor.author","Holzendorf, V."],["dc.contributor.author","Gelbrich, Goetz"],["dc.contributor.author","Duengen, H-D"],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Pieske, Burkert M."],["dc.contributor.author","Edelmann, F."],["dc.date.accessioned","2018-11-07T09:57:25Z"],["dc.date.available","2018-11-07T09:57:25Z"],["dc.date.issued","2015"],["dc.format.extent","281"],["dc.identifier.isi","000366200403095"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/37153"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-blackwell"],["dc.publisher.place","Hoboken"],["dc.relation.issn","1879-0844"],["dc.relation.issn","1388-9842"],["dc.title","Vitamin D deficiency and the prognosis of patients suffering from diastolic dysfunction or heart failure with preserved ejection fraction"],["dc.type","conference_abstract"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","1067"],["dc.bibliographiccitation.issue","8"],["dc.bibliographiccitation.journal","European Journal of Heart Failure"],["dc.bibliographiccitation.lastpage","1074"],["dc.bibliographiccitation.volume","19"],["dc.contributor.author","Edelmann, Frank"],["dc.contributor.author","Bobenko, Anna"],["dc.contributor.author","Gelbrich, Götz"],["dc.contributor.author","Hasenfuss, Gerd"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Duvinage, André"],["dc.contributor.author","Schwarz, Silja"],["dc.contributor.author","Mende, Meinhard"],["dc.contributor.author","Prettin, Christiane"],["dc.contributor.author","Trippel, Tobias"],["dc.contributor.author","Lindhorst, Ruhdja"],["dc.contributor.author","Morris, Daniel"],["dc.contributor.author","Pieske-Kraigher, Elisabeth"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Düngen, Hans-Dirk"],["dc.contributor.author","Wachter, Rolf"],["dc.contributor.author","Halle, Martin"],["dc.contributor.author","Pieske, Burkert"],["dc.date.accessioned","2018-04-23T11:48:12Z"],["dc.date.available","2018-04-23T11:48:12Z"],["dc.date.issued","2017"],["dc.description.abstract","Heart failure with preserved ejection fraction (HFpEF) is a common disease with high incidence and increasing prevalence. Patients suffer from functional limitation, poor health‐related quality of life, and reduced prognosis. A pilot study in a smaller group of HFpEF patients showed that structured, supervised exercise training (ET) improves maximal exercise capacity, diastolic function, and physical quality of life. However, the long‐term effects of ET on patient‐related outcomes remain unclear in HFpEF. The primary objective of the Exercise training in Diastolic Heart Failure (Ex‐DHF) trial is to investigate whether a 12 month supervised ET can improve a clinically meaningful composite outcome score in HFpEF patients. Components of the outcome score are all‐cause mortality, hospitalizations, NYHA functional class, global self‐rated health, maximal exercise capacity, and diastolic function. After undergoing baseline assessments to determine whether ET can be performed safely, 320 patients at 11 trial sites with stable HFpEF are randomized 1:1 to supervised ET in addition to usual care or to usual care alone. Patients randomized to ET perform supervised endurance/resistance ET (3 times/week at a certified training centre) for 12 months. At baseline and during follow‐up, anthropometry, echocardiography, cardiopulmonary exercise testing, and health‐related quality of life evaluation are performed. Blood samples are collected to examine various biomarkers. Overall physical activity, training sessions, and adherence are monitored and documented throughout the study using patient diaries, heart rate monitors, and accelerometers. The Ex‐DHF trial is the first multicentre trial to assess the long‐term effects of a supervised ET programme on different outcome measures in patients with HFpEF."],["dc.identifier.doi","10.1002/ejhf.862"],["dc.identifier.gro","3142337"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/13472"],["dc.language.iso","en"],["dc.notes.intern","lifescience updates Crossref Import"],["dc.notes.status","final"],["dc.relation.issn","1388-9842"],["dc.title","Exercise training in Diastolic Heart Failure (Ex-DHF): rationale and design of a multicentre, prospective, randomized, controlled, parallel group trial"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dc.type.peerReviewed","no"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","E120"],["dc.bibliographiccitation.issue","13"],["dc.bibliographiccitation.journal","DMW - Deutsche Medizinische Wochenschrift"],["dc.bibliographiccitation.lastpage","E128"],["dc.bibliographiccitation.volume","140"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Gabriel, F."],["dc.contributor.author","Stahrenberg, Raoul"],["dc.contributor.author","Weber-Krüger, Mark"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Wachter, Rolf"],["dc.contributor.author","Edelmann, Frank"],["dc.date.accessioned","2017-09-07T11:43:47Z"],["dc.date.available","2017-09-07T11:43:47Z"],["dc.date.issued","2015"],["dc.identifier.doi","10.1055/s-0041-102543"],["dc.identifier.gro","3141891"],["dc.identifier.isi","000357031900001"],["dc.identifier.pmid","26115140"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/2222"],["dc.notes.intern","WoS Import 2017-03-10"],["dc.notes.status","final"],["dc.notes.submitter","PUB_WoS_Import"],["dc.publisher","Georg Thieme Verlag Kg"],["dc.relation.eissn","1439-4413"],["dc.relation.issn","0012-0472"],["dc.title","GDF-15, MRproADM, CTproET1 and CTproAVP in Patients with asymptomatic diastolic Dysfunction"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","53"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","ESC Heart Failure"],["dc.bibliographiccitation.lastpage","62"],["dc.bibliographiccitation.volume","5"],["dc.contributor.author","Bobenko, Anna"],["dc.contributor.author","Bartels, Inke"],["dc.contributor.author","Münch, Marlene"],["dc.contributor.author","Trippel, Tobias"],["dc.contributor.author","Lindhorst, Ruhdja"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Halle, Martin"],["dc.contributor.author","Duvinage, André"],["dc.contributor.author","Düngen, Hans-Dirk"],["dc.contributor.author","Gelbrich, Götz"],["dc.contributor.author","Tschöpe, Carsten"],["dc.contributor.author","Hasenfuss, Gerd"],["dc.contributor.author","Wachter, Rolf"],["dc.contributor.author","Pieske, Burkert"],["dc.contributor.author","Edelmann, Frank"],["dc.date.accessioned","2018-04-23T11:48:01Z"],["dc.date.available","2018-04-23T11:48:01Z"],["dc.date.issued","2018"],["dc.description.abstract","Aims Heart failure with preserved ejection fraction (HFpEF) remains a common condition with no pharmacological treatment. Physical activity (PA) improves symptoms and quality of life (QoL), but no clear recommendations exist on PA in HFpEF patients. We investigated the association of PA (amount/intensity) on clinical phenotype in HFpEF. Methods and results The Aldosterone in Diastolic Heart Failure trial investigated spironolactone vs. placebo in stable HFpEF patients. At baseline, all patients underwent detailed phenotypization including echocardiography, cardiopulmonary exercise testing, 6 minute walking test (6MWT), and QoL assessment (36‐item Short‐Form questionnaire). PA was assessed by a self‐report questionnaire, classified in metabolic equivalents of task (MET) and analysed with regard to exercise capacity, diastolic function, and QoL. Four hundred twenty‐two patients (52% women, age 67 ± 8 years, New York Heart Association II and III) were classified by weekly MET hours into a low (<70), middle (70–140), or high (>140) level of PA. Total PA correlated positively with 6MWT distance (r = 0.17; P = 0.002) and physical function of QoL (r = 0.10; P = 0.05), but not with peak oxygen uptake (peakVO2). In contrast, both 6MWT distance and peakVO2 were significantly higher in patients who performed high‐intensity PA for >8 h/week (P < 0.001, P = 0.02, respectively). Time of high‐intensity PA was related to higher 6MWT distance (r = 0.21, P < 0.001), peakVO2, and better physical function of QoL (both r = 0.13, P = 0.01), whereas low‐intensity PA did not show significant associations. Interestingly, PA was not related to any measure of diastolic function. Conclusions A higher amount of PA is related to higher submaximal exercise capacity and physical function of QoL. Regarding maximal exercise capacity, only high‐intensity PA showed significant association in HFpEF patients."],["dc.identifier.doi","10.1002/ehf2.12227"],["dc.identifier.gro","3142318"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/13451"],["dc.language.iso","en"],["dc.notes.intern","lifescience updates Crossref Import"],["dc.notes.status","final"],["dc.relation.issn","2055-5822"],["dc.title","Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction"],["dc.type","journal_article"],["dc.type.internalPublication","unknown"],["dc.type.peerReviewed","no"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","ehf2.14131"],["dc.bibliographiccitation.journal","ESC Heart Failure"],["dc.contributor.author","Hashemi, Djawid"],["dc.contributor.author","Mende, Meinhard"],["dc.contributor.author","Trippel, Tobias D."],["dc.contributor.author","Petutschnigg, Johannes"],["dc.contributor.author","Hasenfuss, Gerd"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Herrmann‐Lingen, Christoph"],["dc.contributor.author","Feuerstein, Anna"],["dc.contributor.author","Langhammer, Romy"],["dc.contributor.author","Tschöpe, Carsten"],["dc.contributor.author","Edelmann, Frank"],["dc.date.accessioned","2022-10-04T10:21:24Z"],["dc.date.available","2022-10-04T10:21:24Z"],["dc.date.issued","2022"],["dc.identifier.doi","10.1002/ehf2.14131"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/114398"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-600"],["dc.relation.eissn","2055-5822"],["dc.relation.issn","2055-5822"],["dc.title","Evaluation of the HFA‐PEFF Score: results from the prospective DIAST‐CHF cohort"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","582"],["dc.bibliographiccitation.issue","5"],["dc.bibliographiccitation.journal","European Journal of Preventive Cardiology"],["dc.bibliographiccitation.lastpage","593"],["dc.bibliographiccitation.volume","22"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Wachter, Rolf"],["dc.contributor.author","Gelbrich, Götz"],["dc.contributor.author","Duengen, Hans-Dirk"],["dc.contributor.author","Duvinage, Andre"],["dc.contributor.author","Hoischen, Nadine"],["dc.contributor.author","von Oehsen, Karima"],["dc.contributor.author","Schwarz, Silja"],["dc.contributor.author","Hasenfuß, Gerd"],["dc.contributor.author","Halle, Martin"],["dc.contributor.author","Pieske, Burkert"],["dc.contributor.author","Edelmann, Frank"],["dc.date.accessioned","2017-09-07T11:44:26Z"],["dc.date.available","2017-09-07T11:44:26Z"],["dc.date.issued","2015"],["dc.description.abstract","Background Despite suffering from poor prognosis, progressive exercise intolerance, and impaired quality of life (QoL), effective therapeutic strategies in heart failure with preserved ejection fraction (HFpEF) are sparse. Exercise training (ET) improves physical QoL in HFpEF, but the effects on other aspects of QoL are unknown. Methods The multicentre, prospective, randomized, controlled Exercise training in Diastolic Heart Failure Pilot study included 64 HFpEF patients (657 years, 56% female). They were randomized to supervised endurance/resistance training in addition to usual care (ET, n=44) or usual care alone (UC, n=20). At baseline and after 3 months, QoL was assessed (36-item Short-form Health Survey (SF-36), Minnesota Living With Heart Failure Questionnaire (MLWHFQ), and Patient Health Questionnaire (PHQ-9). Results Exercise improved the following SF-36 dimensions: physical functioning (p<0.001, p=0.001 vs. UC), bodily pain (p=0.046), general health perception (p<0.001, p=0.016 vs. UC), general mental health (p= 0.002), vitality (p=0.003), social functioning (p<0.001) physical (p<0.001, p=0.001 vs. UC), and mental component score (p=0.030). ET did not improve role limitations due to physical and emotional problems. The MLWHFQ total scale (p<0.001) and the MLWHFQ physical limitation scale (p<0.001, p=0.04 vs. UC) also improved with ET. The MLWHFQ emotional limitation scale did not change with ET. With ET, also the PHQ-9 total score improved significantly (p=0.004, p=0.735 vs. UC). Conclusions In patients with HFpEF, exercise training improved emotional status, physical and social dimensions of QoL as well as symptoms of depression from pre to post test. Physical dimensions of QoL and general health perception also improved significantly with exercise in comparison to usual care."],["dc.identifier.doi","10.1177/2047487314526071"],["dc.identifier.gro","3141917"],["dc.identifier.isi","000352791900005"],["dc.identifier.pmid","24627449"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/2511"],["dc.notes.intern","WoS Import 2017-03-10"],["dc.notes.status","final"],["dc.notes.submitter","PUB_WoS_Import"],["dc.publisher","Sage Publications Ltd"],["dc.relation.eissn","2047-4881"],["dc.relation.issn","2047-4873"],["dc.title","Effects of exercise training on different quality of life dimensions in heart failure with preserved ejection fraction: the Ex-DHF-P trial"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.subtype","original"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.artnumber","ehf2.14167"],["dc.bibliographiccitation.journal","ESC Heart Failure"],["dc.contributor.author","Eidizadeh, Abass"],["dc.contributor.author","Schnelle, Moritz"],["dc.contributor.author","Leha, Andreas"],["dc.contributor.author","Edelmann, Frank"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Werhahn, Stefanie Maria"],["dc.contributor.author","Binder, Lutz"],["dc.contributor.author","Wachter, Rolf"],["dc.date.accessioned","2022-11-01T10:16:34Z"],["dc.date.available","2022-11-01T10:16:34Z"],["dc.date.issued","2022"],["dc.identifier.doi","10.1002/ehf2.14167"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/116600"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-605"],["dc.relation.eissn","2055-5822"],["dc.relation.issn","2055-5822"],["dc.title","Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST‐CHF study"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.journal","ESC Heart Failure"],["dc.contributor.author","Werhahn, Stefanie M."],["dc.contributor.author","Becker, Christian"],["dc.contributor.author","Mende, Meinhard"],["dc.contributor.author","Haarmann, Helge"],["dc.contributor.author","Nolte, Kathleen"],["dc.contributor.author","Laufs, Ulrich"],["dc.contributor.author","Zeynalova, Samira"],["dc.contributor.author","Löffler, Markus"],["dc.contributor.author","Dagres, Nikolaos"],["dc.contributor.author","Husser, Daniela"],["dc.contributor.author","Wachter, Rolf"],["dc.date.accessioned","2022-01-11T14:08:13Z"],["dc.date.available","2022-01-11T14:08:13Z"],["dc.date.issued","2021"],["dc.identifier.doi","10.1002/ehf2.13703"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/97966"],["dc.language.iso","en"],["dc.notes.intern","DOI-Import GROB-507"],["dc.relation.eissn","2055-5822"],["dc.relation.issn","2055-5822"],["dc.rights.uri","http://creativecommons.org/licenses/by-nc/4.0/"],["dc.title","NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","200"],["dc.bibliographiccitation.issue","2"],["dc.bibliographiccitation.journal","Herz"],["dc.bibliographiccitation.lastpage","208"],["dc.bibliographiccitation.volume","42"],["dc.contributor.author","Lashki, Diana Jahandar"],["dc.contributor.author","Zelenak, C."],["dc.contributor.author","Tahirovic, E. Elvis"],["dc.contributor.author","Trippel, Tobias D."],["dc.contributor.author","Kolip, P."],["dc.contributor.author","Busjahn, Andreas"],["dc.contributor.author","Rauchfuss, M."],["dc.contributor.author","Nolte, K."],["dc.contributor.author","Schwarz, S."],["dc.contributor.author","Wachter, R. Rolf"],["dc.contributor.author","Gelbrich, Goetz"],["dc.contributor.author","Halle, Martin"],["dc.contributor.author","Pieske, Burkert M."],["dc.contributor.author","Herrmann-Lingen, Christoph"],["dc.contributor.author","Edelmann, F."],["dc.contributor.author","Duengen, Hans-Dirk"],["dc.date.accessioned","2018-11-07T10:25:35Z"],["dc.date.available","2018-11-07T10:25:35Z"],["dc.date.issued","2017"],["dc.description.abstract","Improvement in the quality of life (QoL) is a major goal of therapy for heart failure (HF) patients. Physical well-being as an important component of QoL has not yet been sufficiently covered by disease-specific assessment instruments. The aim of the study was to validate the questionnaire for assessing subjective physical well-being (FEW16) in HF patients with preserved ejection fraction (HFpEF) from the exercise training in diastolic heart failure (Ex-DHFaEuroP) trial. A total of 64 HFpEF patients (65 years, 56 % female) were randomized to usual routine treatment with (n = 44) or without training (n = 20). At baseline and 3 months, patients were clinically evaluated and assessed using appropriate questionnaires on the QoL (SF36), physical well-being (FEW16) and depression (PHQ-D). The FEW16 showed good values for Cronbachs' alpha coefficients (0.85-0.93). The cross-validity with SF36 and PHQ-D was highly significant but more so for psychological aspects. At baseline, the FEW16 score correlated with age, the subscale resilience with age and the 6 min walking distance test. At follow-up, the total and resilience scores had improved in the training group. In contrast to the SF36, the FEW16 did not detect differences between the groups in Ex-DHFaEuroP. The FEW16 questionnaire showed good internal consistency and correlation with SF36, its total score and resilience had improved after training; however, it did not reflect different changes between the study groups. The FEW16 is therefore more suited to assess general/mental well-being than the subjective physical well-being."],["dc.identifier.doi","10.1007/s00059-016-4458-9"],["dc.identifier.isi","000398821200011"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/42883"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","PUB_WoS_Import"],["dc.publisher","Urban & Vogel"],["dc.relation.issn","1615-6692"],["dc.relation.issn","0340-9937"],["dc.title","Assessment of subjective physical well-being in heart failure. Validation of the FEW16 questionnaire"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]